The DOI matches its Crossref record; 184 of the 184 references it cites were found in a registry or an index.
ERS clinical practice guidelines on treatment of sarcoidosis
Open accessAbstract
Background: The major reasons to treat sarcoidosis are to lower the morbidity and mortality risk or to improve quality of life (QoL). The indication for treatment varies depending on which manifestation is the cause of symptoms: lungs, heart, brain, skin or other manifestations. While glucocorticoids remain the first choice for initial treatment of symptomatic disease, prolonged use is associated with significant toxicity. Glucocorticoid-sparing alternatives are available. The presented treatment guidelines aim to provide guidance to physicians treating the very heterogenous sarcoidosis manifestations. Methods: A European Respiratory Society Task Force committee composed of clinicians, methodologists and patients with experience in sarcoidosis developed recommendations based on the GRADE (Grading of Recommendations, Assessment, Development and Evaluations) methodology. The committee developed eight PICO (Patients, Intervention, Comparison, Outcomes) questions and these were used to make specific evidence-based recommendations. Results: The Task Force committee delivered 12 recommendations for seven PICOs. These included treatment of pulmonary, cutaneous, cardiac and neurologic disease as well as fatigue. One PICO question regarding small-fibre neuropathy had insufficient evidence to support a recommendation. In addition to the recommendations, the committee provided information on how they use alternative treatments, when there was insufficient evidence to support a recommendation. Conclusions: There are many treatments available to treat sarcoidosis. Given the diverse nature of the disease, treatment decisions require an assessment of organ involvement, risk for significant morbidity, and impact on QoL of the disease and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Stang, A. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9491-z · Cited by 17,396
Jones, P. W., Quirk, F. H., Baveystock, C. M., & Littlejohns, P. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.6.1321 · Cited by 3,035
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
Flaherty, K. R., Wells, A. U., Cottin, V., Devaraj, A., Walsh, S. L. F., Inoue, Y., Richeldi, L., Kolb, M., Tetzlaff, K., Stowasser, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1908681 · Cited by 2,403
Self-citation(1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.2.ats4-99 · Cited by 1,902
Clinical Characteristics of Patients in a Case Control Study of Sarcoidosis
BAUGHMAN, R. P., TEIRSTEIN, A. S., JUDSON, M. A., ROSSMAN, M. D., YEAGER, H., BRESNITZ, E. A., DePALO, L., HUNNINGHAKE, G., IANNUZZI, M. C., JOHNS, C. J., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.10.2104046 · Cited by 1,808
Self-citationBirnie, D. H., Sauer, W. H., Bogun, F., Cooper, J. M., Culver, D. A., Duvernoy, C. S., Judson, M. A., Kron, J., Mehta, D., Cosedis Nielsen, J., et al. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.03.043 · Cited by 1,479
Self-citationHunninghake, G. W., Costabel, U., Ando, M., Baughman, R. P., Cordier, J. F., du Bois, R. M., Eklúnd, A., Kitaichi, M., Lynch, J. P., Rizzato, G., et al. (1999) · PubMed · Cited by 1,324
Self-citationAlonso-Coello, P., Schünemann, H. J., Moberg, J., Brignardello-Petersen, R., Akl, E. A., Davoli, M., Treweek, S., Mustafa, R. A., Rada, G., Rosenbaum, S., et al. (2016) · BMJ · doi:10.1136/bmj.i2016 · Cited by 1,317
Andrews, J. C., Schünemann, H. J., Oxman, A. D., Pottie, K., Meerpohl, J. J., Coello, P. A., Rind, D., Montori, V. M., Brito, J. P., Norris, S., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.02.003 · Cited by 1,315
Newman, L. S., Rose, C. S., & Maier, L. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361706 · Cited by 1,235
Valeyre, D., Prasse, A., Nunes, H., Uzunhan, Y., Brillet, P.-Y., & Müller-Quernheim, J. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60680-7 · Cited by 1,087
Self-citationCrouser, E. D., Maier, L. A., Wilson, K. C., Bonham, C. A., Morgenthau, A. S., Patterson, K. C., Abston, E., Bernstein, R. C., Blankstein, R., Chen, E. S., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202002-0251st · Cited by 1,086
Self-citationCardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis.
Silverman, K. J., Hutchins, G. M., & Bulkley, B. H. (1978) · Circulation · doi:10.1161/01.cir.58.6.1204 · Cited by 984
Detection of Myocardial Damage in Patients With Sarcoidosis
Patel, M. R., Cawley, P. J., Heitner, J. F., Klem, I., Parker, M. A., Jaroudi, W. A., Meine, T. J., White, J. B., Elliott, M. D., Kim, H. W., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.851352 · Cited by 719
Infliximab Therapy in Patients with Chronic Sarcoidosis and Pulmonary Involvement
Baughman, R. P., Drent, M., Kavuru, M., Judson, M. A., Costabel, U., du Bois, R., Albera, C., Brutsche, M., Davis, G., Donohue, J. F., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200603-402oc · Cited by 714
Self-citationBlankstein, R., Osborne, M., Naya, M., Waller, A., Kim, C. K., Murthy, V. L., Kazemian, P., Kwong, R. Y., Tokuda, M., Skali, H., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.022 · Cited by 709
Adalimumab in Patients with Active Noninfectious Uveitis
Jaffe, G. J., Dick, A. D., Brézin, A. P., Nguyen, Q. D., Thorne, J. E., Kestelyn, P., Barisani-Asenbauer, T., Franco, P., Heiligenhaus, A., Scales, D., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1509852 · Cited by 674
Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Heart Rhythm · doi:10.1016/j.hrthm.2017.10.035 · Cited by 669
Yazaki, Y., Isobe, M., Hiroe, M., Morimoto, S.-I., Hiramitsu, S., Nakano, T., Izumi, T., & Sekiguchi, M. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01978-6 · Cited by 664
Prognosis of Intrathoracic Sarcoidosis in England
Scadding, J. G. (1961) · BMJ · doi:10.1136/bmj.2.5261.1165 · Cited by 638
Cardiac Sarcoidosis: Epidemiology, Characteristics, and Outcome Over 25 Years in a Nationwide Study
Kandolin, R., Lehtonen, J., Airaksinen, J., Vihinen, T., Miettinen, H., Ylitalo, K., Kaikkonen, K., Tuohinen, S., Haataja, P., Kerola, T., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.011522 · Cited by 582
Emerging biological roles for erythropoietin in the nervous system
Brines, M., & Cerami, A. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1687 · Cited by 523
CMR Imaging Predicts Death and Other Adverse Events in Suspected Cardiac Sarcoidosis
Greulich, S., Deluigi, C. C., Gloekler, S., Wahl, A., Zürn, C., Kramer, U., Nothnagel, D., Bültel, H., Schumm, J., Grün, S., et al. (2013) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2012.10.021 · Cited by 462
Measuring fatigue in sarcoidosis: The Fatigue Assessment Scale (FAS)
de Vries, J., Michielsen, H., Van Heck, G. L., & Drent, M. (2004) · British Journal of Health Psychology · doi:10.1348/1359107041557048 · Cited by 424
Self-citationSarcoidosis-related Mortality in the United States from 1988 to 2007
Swigris, J. J., Olson, A. L., Huie, T. J., Fernandez-Perez, E. R., Solomon, J., Sprunger, D., & Brown, K. K. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201010-1679oc · Cited by 400
Stern, B. J., Royal, W., Gelfand, J. M., Clifford, D. B., Tavee, J., Pawate, S., Berger, J. R., Aksamit, A. J., Krumholz, A., Pardo, C. A., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.2295 · Cited by 398
Self-citationJudson, M. A., Boan, A. D., & Lackland, D. T. (2012) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 351
Self-citationBritish Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment.
Gibson, G. J., Prescott, R. J., Muers, M. F., Middleton, W. G., Mitchell, D. N., Connolly, C. K., & Harrison, B. D. (1996) · Thorax · doi:10.1136/thx.51.3.238 · Cited by 348
Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial.
Baughman, R. P., Winget, D., & Lower, E. E. (2000) · PubMed · Cited by 344
Self-citationAgnello, D., Bigini, P., Villa, P., Mennini, T., Cerami, A., Brines, M. L., & Ghezzi, P. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03239-0 · Cited by 334
Diagnosis and Management of Neurological Sarcoidosis
Lower, E. E. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.16.1864 · Cited by 330
Self-citationEfficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial
Judson, M. A., Baughman, R. P., Costabel, U., Flavin, S., Lo, K. H., Kavuru, M. S., Drent, M., & the Centocor T48 Sarcoidosis investigators (2008) · European Respiratory Journal · doi:10.1183/09031936.00051907 · Cited by 324
Self-citationGottlieb, J. E., Israel, H. L., Steiner, R. M., Triolo, J., & Patrick, H. (1997) · Chest · doi:10.1378/chest.111.3.623 · Cited by 310
Methotrexate vs Azathioprine in Second-line Therapy of Sarcoidosis
Vorselaars, A. D. M., Wuyts, W. A., Vorselaars, V. M. M., Zanen, P., Deneer, V. H. M., Veltkamp, M., Thomeer, M., van Moorsel, C. H. M., & Grutters, J. C. (2013) · Chest · doi:10.1378/chest.12-1728 · Cited by 282
Self-citationCardiac Sarcoidosis: A Retrospective Study of 41 Cases
Chapelon-Abric, C., de Zuttere, D., Duhaut, P., Veyssier, P., Wechsler, B., Huong, D. L. T., de Gennes, C., Papo, T., Blétry, O., Godeau, P., et al. (2004) · Medicine · doi:10.1097/01.md.0000145367.17934.75 · Cited by 261
Corticosteroid Therapy for Cardiac Sarcoidosis: A Systematic Review
Sadek, M. M., Yung, D., Birnie, D. H., Beanlands, R. S., & Nery, P. B. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.02.004 · Cited by 258
Intraepidermal nerve fiber density and its application in sarcoidosis
Bakkers, M., Merkies, I. S. J., Lauria, G., Devigili, G., Penza, P., Lombardi, R., Hermans, M. C. E., van Nes, S. I., De Baets, M., & Faber, C. G. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bacf05 · Cited by 250
Treatment of chronic sarcoidosis with an azathioprine/prednisolone regimen
Muller-Quernheim, J., Kienast, K., Held, M., Pfeifer, S., & Costabel, U. (1999) · European Respiratory Journal · doi:10.1183/09031936.99.14511179 · Cited by 244
Predictors of mortality in pulmonary sarcoidosis
Kirkil, G., Lower, E. E., & Baughman, R. P. (2018) · Chest · doi:10.1016/j.chest.2017.07.008 · Cited by 243
Self-citationOutcome of the treatment for sarcoidosis.
Hunninghake, G. W., Gilbert, S., Pueringer, R., Dayton, C., Floerchinger, C., Helmers, R., Merchant, R., Wilson, J., Galvin, J., & Schwartz, D. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.149.4.8143052 · Cited by 238
Löfgren's Syndrome: Human Leukocyte Antigen Strongly Influences the Disease Course
Grunewald, J., & Eklund, A. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200807-1082oc · Cited by 234
Small fiber neuropathy: A burning problem
Tavee, J., & Zhou, L. (2009) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.76a.08070 · Cited by 234
An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study
Walsh, S. L., Wells, A. U., Sverzellati, N., Keir, G. J., Calandriello, L., Antoniou, K. M., Copley, S. J., Devaraj, A., Maher, T. M., Renzoni, E., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70276-5 · Cited by 232
Self-citationMurtagh, G., Laffin, L. J., Beshai, J. F., Maffessanti, F., Bonham, C. A., Patel, A. V., Yu, Z., Addetia, K., Mor-Avi, V., Moss, J. D., et al. (2016) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.115.003738 · Cited by 221
Small fibre neuropathy in sarcoidosis
Hoitsma, E., Marziniak, M., Faber, C., Reulen, J., Sommer, C., De Baets, M., & Drent, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08912-2 · Cited by 220
Self-citationSafety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis
Judson, M. A., Baughman, R. P., Costabel, U., Drent, M., Gibson, K. F., Raghu, G., Shigemitsu, H., Barney, J. B., Culver, D. A., Hamzeh, N. Y., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00000914 · Cited by 217
Self-citationHulten, E., Agarwal, V., Cahill, M., Cole, G., Vita, T., Parrish, S., Bittencourt, M. S., Murthy, V. L., Kwong, R., Di Carli, M. F., et al. (2016) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.116.005001 · Cited by 216
Two year prognosis of sarcoidosis: the ACCESS experience.
Judson, M. A., Baughman, R. P., Thompson, B. W., Teirstein, A. S., Ml, T., Rossman, Yeager, H., McLennan, G., Bresnitz, E. A., DePalo, L., et al. (2003) · PubMed · Cited by 211
Self-citationSix-Minute Walk Test and Health Status Assessment in Sarcoidosis
Baughman, R. P., Sparkman, B. K., & Lower, E. E. (2007) · Chest · doi:10.1378/chest.06-2822 · Cited by 203
Self-citationCorticosteroids for pulmonary sarcoidosis
Paramothayan, N. S., Lasserson, T. J., & Jones, P. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001114.pub2 · Cited by 198
Corticosteroid Therapy in Pulmonary Sarcoidosis: A Systematic Review
Paramothayan, S., & Jones, P. W. (2002) · JAMA · doi:10.1001/jama.287.10.1301 · Cited by 198
Lower, E. E., Fleishman, S., Cooper, A., Zeldis, J., Faleck, H., Yu, Z., & Manning, D. (2009) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2009.03.011 · Cited by 197
Self-citationInflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis
Mostard, R. L. M., Vöö, S., van Kroonenburgh, M. J. P. G., Verschakelen, J. A., Wijnen, P. A. H. M., Nelemans, P. J., Erckens, R. J., & Drent, M. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.08.012 · Cited by 194
Self-citationThalidomide for Chronic Sarcoidosis
Baughman, R. P., Judson, M. A., Teirstein, A. S., Moller, D. R., & Lower, E. E. (2002) · Chest · doi:10.1378/chest.122.1.227 · Cited by 194
Self-citationAdalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis
Erckens, R. J., Mostard, R. L. M., Wijnen, P. A. H. M., Schouten, J. S., & Drent, M. (2012) · Graefe's Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-011-1844-0 · Cited by 185
Self-citationRandomized Trial of Prolonged Chloroquine Therapy in Advanced Pulmonary Sarcoidosis
BALTZAN, M., MEHTA, S., KIRKHAM, T. H., & COSIO, M. G. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.1.9809024 · Cited by 183
Effectiveness and safety of leflunomide for pulmonary and extrapulmonary sarcoidosis
Sahoo, D. H., Bandyopadhyay, D., Xu, M., Pearson, K., Parambil, J. G., Lazar, C. A., Chapman, J. T., & Culver, D. A. (2011) · European Respiratory Journal · doi:10.1183/09031936.00195010 · Cited by 173
Self-citationDelphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis
Rahaghi, F. F., Baughman, R. P., Saketkoo, L. A., Sweiss, N. J., Barney, J. B., Birring, S. S., Costabel, U., Crouser, E. D., Drent, M., Gerke, A. K., et al. (2020) · European Respiratory Review · doi:10.1183/16000617.0146-2019 · Cited by 167
Self-citationMethotrexate treatment for sarcoid-associated panuveitis
Dev, S., McCallum, R. M., & Jaffe, G. J. (1999) · Ophthalmology · doi:10.1016/s0161-6420(99)90011-8 · Cited by 166
Ise, T., Hasegawa, T., Morita, Y., Yamada, N., Funada, A., Takahama, H., Amaki, M., Kanzaki, H., Okamura, H., Kamakura, S., et al. (2014) · Heart · doi:10.1136/heartjnl-2013-305187 · Cited by 163
Effectiveness of infliximab in refractory FDG PET-positive sarcoidosis
Vorselaars, A. D. M., Crommelin, H. A., Deneer, V. H. M., Meek, B., Claessen, A. M. E., Keijsers, R. G. M., van Moorsel, C. H. M., & Grutters, J. C. (2015) · European Respiratory Journal · doi:10.1183/09031936.00227014 · Cited by 161
Self-citationToxicity risk from glucocorticoids in sarcoidosis patients
Khan, N. A., Donatelli, C. V., Tonelli, A. R., Wiesen, J., Ribeiro Neto, M. L., Sahoo, D., & Culver, D. A. (2017) · Respiratory Medicine · doi:10.1016/j.rmed.2017.09.003 · Cited by 160
Self-citationTavee, J. O., Karwa, K., Ahmed, Z., Thompson, N., Parambil, J., & Culver, D. A. (2017) · Respiratory Medicine · doi:10.1016/j.rmed.2017.03.011 · Cited by 159
Self-citationEarly Treatment of Stage II Sarcoidosis Improves 5-Year Pulmonary Function
Pietinalho, A., Tukiainen, P., Haahtela, T., Persson, T., & Selroos, O. (2002) · CHEST Journal · doi:10.1378/chest.121.1.24 · Cited by 153
A clinical approach to the use of methotrexate for sarcoidosis
Baughman, R. P., & Lower, E. E. (1999) · Thorax · doi:10.1136/thx.54.8.742 · Cited by 152
Self-citationSlart, R. H. J. A., Glaudemans, A. W. J. M., Lancellotti, P., Hyafil, F., Blankstein, R., Schwartz, R. G., Jaber, W. A., Russell, R. R., Gimelli, A., Rouzet, F., et al. (2017) · Journal of Nuclear Cardiology · doi:10.1007/s12350-017-1043-4 · Cited by 152
Ahmed, I., & Harshad, S. R. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.10.001 · Cited by 149
Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosis
Vorselaars, A. D. M., Verwoerd, A., van Moorsel, C. H. M., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00055213 · Cited by 149
Brines, M. L., Dunne, A. N., van Velzen, M., Proto, P. L., Östenson, C., Kirk, R. I., Petropoulos, I. N., Javed, S., Malik, R. A., Cerami, A., et al. (2014) · Molecular Medicine · doi:10.2119/molmed.2014.00215 · Cited by 149
Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block.
Kato, Y., Morimoto, S., Uemura, A., Hiramitsu, S., Ito, T., & Hishida, H. (2003) · PubMed · Cited by 148
Fatigue Is Associated With Quality of Life in Sarcoidosis Patients
Michielsen, H. J., Drent, M., Peroš-Golubičić, T., & Vries, J. D. (2006) · CHEST Journal · doi:10.1378/chest.130.4.989 · Cited by 146
Self-citationA Controlled Trial of Prednisone Treatment of Sarcoidosis
Israel, H. L., Fouts, D. W., & Beggs, R. A. (1973) · American Review of Respiratory Disease · doi:10.1164/arrd.1973.107.4.609 · Cited by 145
Pariser, R. J., Paul, J., Hirano, S. A., Torosky, C., & Smith, M. K. (2012) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2012.10.056 · Cited by 145
Stagaki, E., Mountford, W. K., Lackland, D. T., & Judson, M. A. (2008) · CHEST Journal · doi:10.1378/chest.08-1347 · Cited by 144
Self-citationJudson, M. A., Chaudhry, H., Louis, A., Lee, K., & Yucel, R. M. (2015) · Respiratory Medicine · doi:10.1016/j.rmed.2015.01.019 · Cited by 143
Self-citationPredicting respiratory failure in sarcoidosis patients.
Baughman, R. P., Winget, D., Bowen, E. H., & Lower, E. E. (1997) · PubMed · Cited by 137
Self-citationLupus pernio: a clinico-radiological study of thirty-five cases
Spiteri, M. A., Matthey, F., GORDON, T., et al. (1985) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1985.tb04859.x · Cited by 137
Peterson, K., McDonagh, M. S., & Fu, R. (2008) · Psychopharmacology · doi:10.1007/s00213-007-0996-4 · Cited by 135
Joyce, E., Ninaber, M. K., Katsanos, S., Debonnaire, P., Kamperidis, V., Bax, J. J., Taube, C., Delgado, V., & Marsan, N. A. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.205 · Cited by 134
Established and experimental medical therapy of pulmonary sarcoidosis
Baughman, R. P., Nunès, H., Sweiss, N., & Lower, E. E. (2013) · European Respiratory Journal · doi:10.1183/09031936.00060612 · Cited by 134
Self-citationManagement of Cardiac Sarcoidosis in the United States
Hamzeh, N. Y., Wamboldt, F. S., & Weinberger, H. D. (2011) · CHEST Journal · doi:10.1378/chest.11-0263 · Cited by 130
Patel, A. S., Siegert, R. J., Creamer, D., Larkin, G. B., Maher, T. M., Renzoni, E. A., Wells, A. U., Higginson, I. J., & Birring, S. S. (2012) · Thorax · doi:10.1136/thoraxjnl-2012-201962 · Cited by 130
Self-citationCytokine Modulation is Necessary for Efficacious Treatment of Experimental Neuropathic Pain
Sacerdote, P., Franchi, S., Moretti, S., Castelli, M., Procacci, P., Magnaghi, V., & Panerai, A. E. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9428-2 · Cited by 126
The small fiber neuropathy screening list: Construction and cross-validation in sarcoidosis
Hoitsma, E., Vries, J. D., & Drent, M. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2010.09.014 · Cited by 126
Self-citationNagai, S., Yokomatsu, T., Tanizawa, K., Ikezoe, K., Handa, T., Ito, Y., Ogino, S., & Izumi, T. (2014) · Internal Medicine · doi:10.2169/internalmedicine.53.0794 · Cited by 122
Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory Sarcoidosis.
Sweiss, N., Noth, I., Mirsaeidi, M. S., Zhang, W., Naureckas, E. T., Hogarth, D. K., Strek, M. E., Caligiuri, P., Machado, R. F., Niewold, T. B., et al. (2014) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 119
Self-citationCharacterization of Chronic Fatigue in Patients With Sarcoidosis in Clinical Remission
Korenromp, I. H. E., Heijnen, C. J., Vogels, O. J. M., van den Bosch, J. M. M., & Grutters, J. C. (2011) · CHEST Journal · doi:10.1378/chest.10-2629 · Cited by 117
Self-citationTreatment of Progressive Pulmonary Sarcoidosis with Cyclosporin A
Wyser, C. P., van Schalkwyk, E. M., Alheit, B., Bardin, P. G., & JOUBERT, J. R. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.5.9506031 · Cited by 116
Long-term outcomes of refractory neurosarcoidosis treated with infliximab
Aubart, F. C., Bouvry, D., Galanaud, D., Dehais, C., Mathey, G., Psimaras, D., Haroche, J., Pottier, C., Hie, M., Mathian, A., et al. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8444-9 · Cited by 115
Self-citationHeij, L. R., Niesters, M., Swartjes, M., Hoitsma, E., Drent, M., Dunne, A. N., Grutters, J. C., Vogels, O. J. M., Brines, M. L., Cerami, A., et al. (2012) · Molecular Medicine · doi:10.2119/molmed.2012.00332 · Cited by 114
Self-citationSobic-Saranovic, D. P., Milojević, I. G., Videnović-Ivanov, J., Vučinić-Mihailović, V., Artiko, V. M., Saranovic, D. Z., Djurić-Stefanović, A., Mašulović, D., Odalović, S., Dudvarski-Ilić, A., et al. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.104380 · Cited by 114
Efficacy of mycophenolate mofetil in sarcoidosis
Hamzeh, N. Y., Voelker, A., Forssén, A. V., Gottschall, E. B., Rose, C. S., Mroz, P. M., & Maier, L. A. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2014.09.013 · Cited by 113
Evidence-based therapy for cutaneous sarcoidosis
Baughman, R. P., & Lower, E. E. (2007) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2007.03.011 · Cited by 113
Self-citationFatigue in sarcoidosis: a systematic review
de Kleijn, W. P. E., Vries, J. D., Lower, E. E., Elfferich, M., Baughman, R. P., & Drent, M. (2009) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e32832d0403 · Cited by 112
Self-citationMcKinzie, B. P., Bullington, W., Mazur, J. E., & Judson, M. A. (2009) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181b97635 · Cited by 109
Self-citationEfficacy of intravenous immunoglobulin for small fiber neuropathy associated with sarcoidosis
Parambil, J. G., Tavee, J. O., Zhou, L., Pearson, K. S., & Culver, D. A. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2010.09.015 · Cited by 109
Self-citationLower, E. E., Harman, S., & Baughman, R. P. (2008) · CHEST Journal · doi:10.1378/chest.07-2952 · Cited by 109
Self-citationCulver, D. A., Dahan, A., Bajorunas, D. R., Jeziorska, M., van Velzen, M., Aarts, L. P. H. J., Tavee, J. O., Tannemaat, M. R., Dunne, A. N., Kirk, R. I., et al. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-21291 · Cited by 107
Self-citationZhou, Y., Lower, E. E., Li, H., Costea, A., Attari, M., & Baughman, R. P. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.08.1457 · Cited by 105
Self-citationTreatment of neurosarcoidosis: A comparative study of methotrexate and mycophenolate mofetil
Bitoun, S., Bouvry, D., Borie, R., Mahévas, M., Sacré, K., Haroche, J., Psimaras, D., Pottier, C., Mathian, A., Hie, M., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000003431 · Cited by 105
Self-citationKazmirczak, F., Chen, K.-H. A., Adabağ, S., von Wald, L. N., Roukoz, H., Benditt, D. G., Okasha, O., Farzaneh‐Far, A., Markowitz, J., Nijjar, P. S., et al. (2019) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.119.007488 · Cited by 101
The Burden of Sarcoidosis Symptoms from a Patient Perspective
Voortman, M., Hendriks, C., Elfferich, M., Bonella, F., Møller, J., Vries, J. D., Costabel, U., & Drent, M. (2019) · Lung · doi:10.1007/s00408-019-00206-7 · Cited by 100
Self-citationManagement and Outcomes of Cardiac Sarcoidosis: A 20-Year Experience in Two Tertiary Care Centres
Fussner, L. A., Karlstedt, E., Hodge, D. O., Fine, N. M., Kalra, S., Carmona, E. M., Utz, J. P., Isaac, D., & Cooper, L. T. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1319 · Cited by 99
Shlobin, O. A., Kouranos, V., Barnett, S. D., Alhamad, E. H., Culver, D. A., Barney, J. B., CORDOVA, F. C., Carmona, E. M., Scholand, M. B., Wijsenbeek, M. S., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.01747-2019 · Cited by 99
Self-citationThe late follow-up of chronic sarcoid patients previously treated with corticosteroids.
Rizzato, G., Montemurro, L. A., & Colombo, P. (1998) · PubMed · Cited by 98
Subcutaneous sarcoidosis-clinicopathological study of 10 cases
Marcoval, J., Mañá, J., Moreno, A., et al. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06815.x · Cited by 98
Dahan, A., Dunne, A. N., Swartjes, M., Proto, P. L., Heij, L. R., Vogels, O. J. M., van Velzen, M., Sarton, E. Y., Niesters, M., Tannemaat, M. R., et al. (2013) · Molecular Medicine · doi:10.2119/molmed.2013.00122 · Cited by 98
Chronic pulmonary aspergillosis complicating sarcoidosis
Uzunhan, Y., Nunès, H., Jeny, F., Lacroix, M., Brun, S., Brillet, P., Martinod, E., Carette, M., Bouvry, D., Charlier, C., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.02396-2016 · Cited by 97
Self-citationSteroid-sparing effects of pentoxifylline in pulmonary sarcoidosis.
Park, M. K., Fontana, Babaali, H., Gilbert-McClain, L. I., Stylianou, M. P., Joo, J., Moss, J., & Manganiello, V. (2009) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 96
Padala, S. K., Peaslee, S., Sidhu, M. S., Steckman, D. A., & Judson, M. A. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.10.101 · Cited by 96
Self-citationAssociation of the TNF-α G-308A polymorphism with TNF-inhibitor response in sarcoidosis
Wijnen, P. A. H. M., Cremers, J. P., Nelemans, P. J., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00169413 · Cited by 95
Sarcoidosis mortality in Sweden: a population-based cohort study
Rossides, M., Kullberg, S., Askling, J., Eklúnd, A., Grünewald, J., & Arkema, E. V. (2018) · European Respiratory Journal · doi:10.1183/13993003.01815-2017 · Cited by 95
Nagai, T., Kohsaka, S., Okuda, S., et al. (2014) · CHEST Journal · doi:10.1378/chest.14-0139 · Cited by 94
Nagai, T., Nagano, N., Sugano, Y., Asaumi, Y., Aiba, T., Kanzaki, H., KUSANO, K. F., Noguchi, T., Yasuda, S., Ogawa, H., et al. (2015) · Circulation Journal · doi:10.1253/circj.cj-14-1275 · Cited by 92
Treatment of sarcoidosis: grading the evidence
James, W. E., & Baughman, R. P. (2018) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2018.1486706 · Cited by 92
Self-citationBroos, C. E., Poell, L. H. C., Looman, C. W. N., et al. (2017) · Respiratory Medicine · doi:10.1016/j.rmed.2017.10.022 · Cited by 91
Management of ocular sarcoidosis.
Baughman, R. P., Lower, E. E., Ingledue, R., & Kaufman, A. H. (2012) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 90
Self-citationRepository corticotropin for Chronic Pulmonary Sarcoidosis
Baughman, R. P., Sweiss, N., Keijsers, R. G. M., Birring, S. S., Shipley, R. T., Saketkoo, L. A., & Lower, E. E. (2017) · Lung · doi:10.1007/s00408-017-9994-4 · Cited by 89
Self-citationBrines, M. L., Culver, D. A., Ferdousi, M., Tannemaat, M. R., van Velzen, M., Dahan, A., & Malik, R. A. (2018) · Scientific Reports · doi:10.1038/s41598-018-23107-w · Cited by 89
Self-citationPredictors of mortality in fibrosing pulmonary sarcoidosis
Jeny, F., Uzunhan, Y., Lacroix, M., Gille, T., Brillet, P., Nardi, A., Bouvry, D., Planès, C., Nunès, H., & Valeyre, D. (2020) · Respiratory Medicine · doi:10.1016/j.rmed.2020.105997 · Cited by 89
Self-citationDrake, W. P., Oswald-Richter, K. A., Richmond, B. W., Isom, J., Burke, V. E., Algood, H. M. S., Braun, N. A., Taylor, T. R., Pandit, K. V., Aboud, C., et al. (2013) · JAMA Dermatology · doi:10.1001/jamadermatol.2013.4646 · Cited by 88
Armodafinil for Sarcoidosis-Associated Fatigue: A Double-Blind, Placebo-Controlled, Crossover Trial
Lower, E. E., Malhotra, A., Surdulescu, V., & Baughman, R. P. (2012) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2012.02.016 · Cited by 87
Self-citationEndpoints for clinical trials of sarcoidosis.
Baughman, R. P., Drent, M., Culver, D. A., Grutters, J. C., Handa, T., Humbert, M. J. C., Judson, M. A., Lower, E. E., Mana, J., Pereira, C. A., et al. (2012) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 85
Self-citationRotenberg, C., Besnard, V., Brillet, P., Giraudier, S., Nunès, H., & Valeyre, D. (2018) · European Respiratory Journal · doi:10.1183/13993003.01482-2018 · Cited by 84
Self-citationBallul, T., Borie, R., Crestani, B., Daugas, É., Descamps, V., Dieudé, P., Dossier, A., Extramiana, F., Gysel, D. V., Papo, T., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.11.131 · Cited by 82
Sarcoidosis and Small-fiber Neuropathy
Tavee, J. O., & Culver, D. A. (2011) · Current Pain and Headache Reports · doi:10.1007/s11916-011-0180-8 · Cited by 81
Self-citationSheppard, J. D., Joshi, A. D., Betts, K. A., Hudgens, S. A., Tari, S. R., Chen, N., Skup, M., & Dick, A. D. (2017) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2017.0603 · Cited by 80
Infliximab for Refractory Cardiac Sarcoidosis
Harper, L. J., McCarthy, M., Neto, M. L. R., Hachamovitch, R., Pearson, K. S., Bonanno, B., Shaia, J., Brunken, R. C., Joyce, E., & Culver, D. A. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.07.067 · Cited by 79
Self-citationClinical outcomes in sarcoidosis after cessation of infliximab treatment
Panselinas, E., Rodgers, J. K., & Judson, M. A. (2009) · Respirology · doi:10.1111/j.1440-1843.2009.01518.x · Cited by 77
Self-citationImprovement of small fiber neuropathy in a sarcoidosis patient after treatment with infliximab.
Hoitsma, E., Faber, C. G., van Santen‐Hoeufft, M. H. S., Vries, J. D., Reulen, J. P. H., & Drent, M. (2006) · Research portal (Tilburg University) · Cited by 75
Self-citationPlasma exchange and intravenous immunoglobulins: Mechanism of action in immune-mediated neuropathies
Lehmann, H. C., & Hartung, H. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.09.015 · Cited by 74
Usefulness of Cardiac Troponins as Markers of Early Treatment Response in Cardiac Sarcoidosis
Kandolin, R. M., Lehtonen, J. Y. A., Airaksinen, J. K. E., Vihinen, T., Miettinen, H., Kaikkonen, K., Haataja, P., Kerola, T. V., & Kupari, M. M. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.06.021 · Cited by 73
Mohsen, A., Jiménez, A., HOOD, R. E., Dickfeld, T. M., SALIARIS, A. P., Shorofsky, S. R., & SABA, M. M. (2013) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12302 · Cited by 69
du Bois, R. M., Greenhalgh, P. M., Southcott, A., Johnson, N. M., & Harris, T. A. J. (1999) · European Respiratory Journal · doi:10.1183/09031936.99.13613519 · Cited by 65
A retrospective pilot study examining the use of Acthar gel in sarcoidosis patients
Baughman, R. P., Barney, J. B., O’Hare, L., et al. (2015) · Respiratory Medicine · doi:10.1016/j.rmed.2015.11.007 · Cited by 65
Self-citationSmall fiber neuropathy: a disabling and underrecognized syndrome
Voortman, M., Fritz, D., Vogels, O. J. M., Eftimov, F., van de Beek, D., Brouwer, M. C., & Drent, M. (2017) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000413 · Cited by 65
Self-citationRibeiro Neto, M. L., Jellis, C. L., Joyce, E., Callahan, T. D., Hachamovitch, R., & Culver, D. A. (2019) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201902-119cme · Cited by 63
Self-citationBaughman, R. P., Judson, M. A., Lower, E. E., Drent, M., Costabel, U., Flavin, S. K., Lo, K. H., & Barnathan, E. S. (2016) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 63
Self-citationEfficacy and safety of infliximab biosimilar Inflectra® in severe sarcoidosis
Schimmelpennink, M. C., Vorselaars, A. D. M., van Beek, F. T., Crommelin, H. A., Deneer, V. H. M., Keijsers, R. G. M., & Veltkamp, M. (2018) · Respiratory Medicine · doi:10.1016/j.rmed.2018.02.009 · Cited by 63
Judson, M. A., Mack, M., Beaumont, J. L., Watt, R. A., Barnathan, E. S., & Victorson, D. E. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201410-1785oc · Cited by 62
Self-citationBenefits of Physical Training in Sarcoidosis
Strookappe, B., Swigris, J. J., Vries, J. D., Elfferich, M., Knevel, T., & Drent, M. (2015) · Lung · doi:10.1007/s00408-015-9784-9 · Cited by 61
Self-citationUngprasert, P., Wetter, D. A., Crowson, C. S., & Matteson, E. L. (2016) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13760 · Cited by 60
The indications for the treatment of sarcoidosis: Wells Law.
Baughman, R. P., Judson, M. A., & Wells, A. U. (2017) · Sarcoidosis vasculitis and diffuse lung diseases · doi:10.36141/svdld.v34i4.6957 · Cited by 60
Self-citationSchramel, F. M. N. H., Golding, R. P., Haakman, C., Sutedja, T. G., de Jong, K., & Postmus, P. E. (1996) · European Respiratory Journal · doi:10.1183/09031936.96.09030406 · Cited by 58
Tocilizumab in sarcoidosis patients failing steroid sparing therapies and anti-TNF agents
Sharp, M., Donnelly, S. C., & Möller, D. R. (2019) · Respiratory Medicine X · doi:10.1016/j.yrmex.2019.100004 · Cited by 58
Calender, A., Lim, C. X., Weichhart, T., Buisson, A., Besnard, V., Rollat‐Farnier, P. A., Bardel, C., Roy, P., Cottin, V., Devouassoux, G., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.00430-2019 · Cited by 58
Self-citationNaz, İ., Özalevli, S., Aktoğu, S., & Sahin, H. D. (2018) · Journal of Cardiopulmonary Rehabilitation and Prevention · doi:10.1097/hcr.0000000000000307 · Cited by 57
Callen, J. P. (1981) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(81)70017-3 · Cited by 57
Karadallı, M. N., Güçlü, M. B., Camcıoğlu, B., Köktürk, N., & Türktaş, H. (2015) · Respiratory Care · doi:10.4187/respcare.04312 · Cited by 56
The prognostic value of quantitating and localizing F-18 FDG uptake in cardiac sarcoidosis
Flores, R. J., Flaherty, K. R., Jin, Z., & Bokhari, S. (2018) · Journal of Nuclear Cardiology · doi:10.1007/s12350-018-01504-y · Cited by 56
Clinical Features and Outcomes of Patients with Sarcoidosis-associated Pulmonary Hypertension
Parikh, K. S., Dahhan, T., Nicholl, L., Ruopp, N. F., Pomann, G., Fortin, T., Tapson, V. F., & Rajagopal, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-40030-w · Cited by 56
Cutaneous sarcoidosis in Asians: a report of 25 patients from Singapore
Chong, W., Tan, H. H., & Tan, S. (2005) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2005.01729.x · Cited by 53
Does physical training reduce fatigue in sarcoidosis?
Marcellis, R. G. J., der Veeke, M. V., Mesters, I., Drent, M., de Bie, R. A., Vries, G. D., & Lenssen, A. F. (2015) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 51
Self-citationBaughman, R. P., & Wells, A. U. (2019) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000612 · Cited by 51
Self-citationNagano, N., Nagai, T., Sugano, Y., Morita, Y., Asaumi, Y., Aiba, T., Kanzaki, H., KUSANO, K. F., Noguchi, T., Yasuda, S., et al. (2015) · Circulation Journal · doi:10.1253/circj.cj-14-1217 · Cited by 50
Rosenbach, M. A., Yeung, H., Chu, E. Y., Kim, E. J., Payne, A. S., Takeshita, J., Vittorio, C. C., Wanat, K. A., Werth, V. P., & Gelfand, J. M. (2013) · JAMA Dermatology · doi:10.1001/jamadermatol.2013.60 · Cited by 50
Nagai, T., Nagano, N., Sugano, Y., Asaumi, Y., Aiba, T., Kanzaki, H., KUSANO, K. F., Noguchi, T., Yasuda, S., Ogawa, H., et al. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.12.033 · Cited by 49
TNF-alpha inhibition for the treatment of cardiac sarcoidosis
Baker, M. C., Sheth, K., Witteles, R. M., Genovese, M. C., Shoor, S., & Simard, J. F. (2019) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2019.11.004 · Cited by 48
Akashi, H., Kato, T., Takayama, H., Naka, Y., FARR, M. A., MANCINI, D. M., & Schulze, P. C. (2012) · Journal of Cardiology · doi:10.1016/j.jjcc.2012.07.013 · Cited by 46
Physical activity and training in sarcoidosis: review and experience-based recommendations
Strookappe, B., Saketkoo, L. A., Elfferich, M., Holland, A. E., Vries, J. D., Knevel, T., & Drent, M. (2016) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2016.1227244 · Cited by 46
Self-citationNational survey on status of steroid therapy for cardiac sarcoidosis in Japan.
Hiramitsu, S., 森本, 紳., Uemura, A., Kato, Y., Kimura, K., Ohtsuki, M., Kato, S., Sugiura, A., Miyagishima, K., Hishida, H., et al. (2005) · PubMed · Cited by 45
Steroid-unresponsive neurosarcoidosis successfully treated with adalimumab
Marnane, M., Lynch, T., Scott, J., Stack, J. P., & Kelly, P. J. (2009) · Journal of Neurology · doi:10.1007/s00415-009-0077-1 · Cited by 41
Quality of Life in Sarcoidosis: Assessment and Management
Vries, J. D., Lower, E. E., & Drent, M. (2010) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0030-1262216 · Cited by 41
Self-citationMaturu, V. N., Rayamajhi, S. J., Agarwal, R., Aggarwal, A. N., Gupta, D., & Mittal, B. R. (2016) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 40
Lingner, H., Buhr-Schinner, H., Hummel, S., van der Meyden, J., Großhennig, A., Nowik, D., & Schultz, K. (2018) · Respiration · doi:10.1159/000486964 · Cited by 39
Wilson, N. J. E., & King, C. M. (1998) · Postgraduate Medical Journal · doi:10.1136/pgmj.74.877.649 · Cited by 39
Wallaert, B., Kyheng, M., Labreuche, J., Stelianides, S., Wémeau-Stervinou, L., & Grosbois, J. (2019) · Respiratory Medicine and Research · doi:10.1016/j.resmer.2019.10.003 · Cited by 36
Miravitlles, M., Tonia, T., Comas, D. R., Roche, N., Genton, C., Vaccaro, V., Welte, T., Gaga, M., & Brusselle, G. (2018) · European Respiratory Journal · doi:10.1183/13993003.00221-2018 · Cited by 33
Self-citationChopra, I., Qin, Y., Kranyak, J., Gallagher, J. R., Heap, K., Carroll, S. L., & Wan, G. J. (2019) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753466619888127 · Cited by 32
Gangemi, A. J., Myers, C. N., Zheng, M., Brown, J., Butler-Lebair, M., CORDOVA, F. C., Marchetti, N. T., Criner, G. J., Gupta, R., & Mamary, A. J. (2019) · Respiratory Medicine · doi:10.1016/j.rmed.2019.09.001 · Cited by 31
Indications for treatment of sarcoidosis
Nunès, H., Jeny, F., Bouvry, D., Uzunhan, Y., & Valeyre, D. (2019) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000604 · Cited by 29
Self-citationKudoh, H., Fujiwara, S., Shiotani, H., Kawai, H., & Hirata, K. (2010) · Annals of Nuclear Medicine · doi:10.1007/s12149-010-0376-8 · Cited by 26
Vis, R., van de Garde, E. M. W., Grutters, J. C., et al. (2020) · European Respiratory Review · doi:10.1183/16000617.0057-2019 · Cited by 23
Self-citationRandomised, placebo-controlled trial of dexamethasone for quality of life in pulmonary sarcoidosis
Vis, R., van de Garde, E. M. W., Meek, B., Korenromp, I. H. E., & Grutters, J. C. (2020) · Respiratory Medicine · doi:10.1016/j.rmed.2020.105936 · Cited by 23
Self-citationOkabe, T., Yakushiji, T., Hiroe, M., Oyama, Y., Igawa, W., Ono, M., Kido, T., Ebara, S., Yamashita, K., Yamamoto, M. H., et al. (2016) · ESC Heart Failure · doi:10.1002/ehf2.12095 · Cited by 21
Caruana, L. B., Redwine, G. D., Rohde, R. E., & Russian, C. J. (2019) · Sarcoidosis vasculitis and diffuse lung diseases · doi:10.36141/svdld.v36i3.7112 · Cited by 17
Efficacy and safety of TNF antagonists in ocular sarcoidosis: data from the French registry STAT.
Marquet, A., Chapelon-Abric, C., Maucort‐Boulch, D., Aubart, F. C., Pérard, L., Bouillet, L., Abad, S., Bielefeld, P., Bouvry, D., André, M. F. J., et al. (2017) · Sarcoidosis vasculitis and diffuse lung diseases · doi:10.36141/svdld.v34i1.5368 · Cited by 12
Self-citationBaughman, R. P., Tillinger, M. N., Qin, Y., Sweiss, N., & Lower, E. E. (2019) · Sarcoidosis vasculitis and diffuse lung diseases · doi:10.36141/svdld.v36i1.7748 · Cited by 11
Self-citationThe effect of race on clinical presentation and outcomes in neurosarcoidosis
Affan, M., Mahajan, A., Rehman, T., Kananeh, M. F., Schultz, L. R., & Cerghet, M. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.117073 · Cited by 9
Research works printed but not linked: 60
- 10.1183/16000617.0145-2019 · doi:10.1183/16000617.0145-2019
- 10.1183/23120541.00141-2018 · doi:10.1183/23120541.00141-2018
- 10.1378/chest.128.2.1062 · DOI · Paper page
- 10.1093/qjmed/hcl038 · doi:10.1093/qjmed/hcl038
- 10.1212/WNL.0000000000004644 · doi:10.1212/wnl.0000000000004644
- 10.1378/chest.125.3.990 · doi:10.1378/chest.125.3.990
- Baughman, 2020, Methotrexate in sarcoidosis: hematologic and hepatic toxicity encountered in a large cohort over a 6 year period, Sarcoidosis Vasc Diffuse Lung Dis, 37, e2020001
- Drent, 2014, Practical eminence and experience-based recommendations for use of TNF-alpha inhibitors in sarcoidosis, Sarcoidosis Vasc Diffuse Lung Dis, 31, 91
- Lower, 2020, Use of third-line therapies in advanced sarcoidosis, Clin Exp Rheumatol, 38, 834
- Baughman, 2004, Leflunomide for chronic sarcoidosis, Sarcoidosis Vasc Diffuse Lung Dis, 21, 43
- Muers, 1997, A simple radiographic scoring method for monitoring pulmonary sarcoidosis: relations between radiographic scores, dyspnoea grade and respiratory function in the British Thoracic Society study of long-term corticosteroid treatment, Sarcoidosis Vasc Diffuse Lung Dis, 14, 46
- 10.2165/00128071-200809030-00003 · doi:10.2165/00128071-200809030-00003
- 10.1183/13993003.00897-2019 · doi:10.1183/13993003.00897-2019
- 10.1016/S0140-6736(67)90493-X · doi:10.1016/s0140-6736(67)90493-x
- 10.1378/chest.116.2.424 · doi:10.1378/chest.116.2.424
- Zaki, 1987, Corticosteroid therapy in sarcoidosis: a 5 year controlled follow-up, NY State J Med, 87, 496
- 10.7326/0003-4819-73-2-207 · doi:10.7326/0003-4819-73-2-207
- 10.1111/j.1365-2796.1994.tb00798.x · doi:10.1111/j.1365-2796.1994.tb00798.x
- Baughman, 2002, Use of fluticasone in acute symptomatic pulmonary sarcoidosis, Sarcoidosis Vasc Diffuse Lung Dis, 19, 198
- Baughman, 2014, Features of sarcoidosis associated with chronic disease, Sarcoidosis Vasc Diffuse Lung Dis, 31, 275
- 10.1136/pgmj.46.538.537 · doi:10.1136/pgmj.46.538.537
- Selroos, 1979, Corticosteroid therapy of pulmonary sarcoidosis, Scand J Respir Dis, 60, 215
- 10.1016/0002-9343(66)90216-6 · doi:10.1016/0002-9343(66)90216-6
- Rossman, 2006, A double-blind, randomized, placebo-controlled trial of infliximab in patients with active pulmonary sarcoidosis, Sarcoidosis Vasc Diffuse Lung Dis, 23, 201
- 10.1001/archinte.1995.00430080088011 · doi:10.1001/archinte.1995.00430080088011
- Fang, 2019, Effectiveness and tolerability of methotrexate in pulmonary sarcoidosis: a single center real-world study, Sarcoidosis Vasc Diffuse Lung Dis, 36, 217
- Siltzbach, 1964, Chloroquine therapy in 43 patients with intrathoracic and cutaneous sarcoidosis, Acta Med Scand, 425, 302S, 10.1111/j.0954-6820.1964.tb05780.x · doi:10.1111/j.0954-6820.1964.tb05780.x
- Minnis, 2016, Adalimumab for refractory pulmonary sarcoidosis, Ir J Med Sci, 185, 969, 10.1007/s11845-015-1363-9 · doi:10.1007/s11845-015-1363-9
- 10.1183/09031936.00224513 · doi:10.1183/09031936.00224513
- Drake, 2013, Effects of broad-spectrum antimycobacterial therapy on chronic pulmonary sarcoidosis, Sarcoidosis Vasc Diffuse Lung Dis, 30, 201
- Drake, 2021, Phase II investigation of the efficacy of antimycobacterial therapy in chronic pulmonary sarcoidosis, Chest, 159, 1902, 10.1016/j.chest.2020.12.027 · doi:10.1016/j.chest.2020.12.027
- Irwin, 2018, Higher priced older pharmaceuticals: how should we respond?, Chest, 153, 23, 10.1016/j.chest.2017.09.042 · doi:10.1016/j.chest.2017.09.042
- 10.1016/j.ccm.2015.08.010 · doi:10.1016/j.ccm.2015.08.010
- 10.1001/archdermatol.2011.2085 · doi:10.1001/archdermatol.2011.2085
- Chang, 2012, Cutaneous sarcoidosis: a case series from a regional hospital in Hong Kong, Hong Kong J Dermatol Venereol, 20, 153
- Tong, 2014, Comparison of cutaneous sarcoidosis with systemic sarcoidosis: a retrospective analysis, Int J Clin Exp Pathol, 7, 372
- Collin, 2010, A retrospective analysis of 34 patients with cutaneous sarcoidosis assessed in a dermatology department, Clin Exp Dermatol, 35, 131, 10.1111/j.1365-2230.2009.03400.x · doi:10.1111/j.1365-2230.2009.03400.x
- Volden, 1992, Successful treatment of chronic skin diseases with clobetasol propionate and a hydrocolloid occlusive dressing, Acta Derm Venereol, 72, 69, 10.2340/00015555726971 · doi:10.2340/00015555726971
- 10.1001/archderm.131.5.617 · doi:10.1001/archderm.131.5.617
- 10.1016/j.jaad.2006.06.019 · doi:10.1016/j.jaad.2006.06.019
- Noe, 2017, High frequency ultrasound: a novel instrument to quantify granuloma burden in cutaneous sarcoidosis, Sarcoidosis Vasc Diffuse Lung Dis, 34, 136
- Droitcourt, 2014, A randomized, investigator-masked, double-blind, placebo-controlled trial on thalidomide in severe cutaneous sarcoidosis, Chest, 146, 1046, 10.1378/chest.14-0015 · doi:10.1378/chest.14-0015
- 10.1016/S0041-3879(67)80033-3 · doi:10.1016/s0041-3879(67)80033-3
- Jones, 1990, Hydroxychloroquine is effective therapy for control of cutaneous sarcoidal granulomas, J Am Acad Dermatol, 23, 487, 10.1016/0190-9622(90)70246-E · doi:10.1016/0190-9622(90)70246-e
- 10.1016/0190-9622(91)70071-9 · doi:10.1016/0190-9622(91)70071-9
- 10.1016/S0022-3476(97)70306-8 · doi:10.1016/s0022-3476(97)70306-8
- Rajendran, 1994, Methotrexate in the treatment of cutaneous sarcoidosis, Sarcoidosis, 11, S335
- 10.1016/j.jcmg.2017.04.020 · doi:10.1016/j.jcmg.2017.04.020
- Chapelon-Abric, 2017, Cardiac sarcoidosis: diagnosis, therapeutic management and prognostic factors, Arch Cardiovasc Dis, 110, 456, 10.1016/j.acvd.2016.12.014 · doi:10.1016/j.acvd.2016.12.014
- Takaya, 2014, Reduction of myocardial inflammation with steroid is not necessarily associated with improvement in left ventricular function in patients with cardiac sarcoidosis: predictors of functional improvement, Int J Cardiol, 176, 522, 10.1016/j.ijcard.2014.07.042 · doi:10.1016/j.ijcard.2014.07.042
- Fujita, 1990, A case with cardiac sarcoidosis. Significance of the effect of steroids on the reversion of advanced atrioventricular block and myocardial scintigraphic abnormalities, Heart Vessels Suppl, 5, 16
- 10.2174/1573403X15666190725121246 · doi:10.2174/1573403x15666190725121246
- Joubert, 2017, Association of prognostic factors and immunosuppressive treatment with long-term outcomes in neurosarcoidosis, JAMA Neurol, 74, 1336, 10.1001/jamaneurol.2017.2492 · doi:10.1001/jamaneurol.2017.2492
- 10.1186/s12883-016-0741-x · doi:10.1186/s12883-016-0741-x
- 10.1001/archinte.1997.00440370104011 · doi:10.1001/archinte.1997.00440370104011 · Paper page
- Metyas, 2014, Neurosarcoidosis mimicking multiple sclerosis successfully treated with methotrexate and adalimumab, Int J Rheum Dis, 17, 214, 10.1111/1756-185X.12122 · doi:10.1111/1756-185x.12122
- 10.1378/chest.124.5.2023 · doi:10.1378/chest.124.5.2023
- Thunold, 2017, Patient reported outcome measures (PROM) in sarcoidosis, Sarcoidosis Vasc Diffuse Lung Dis, 34, 2
- Voortman, 2018, Determinaton of the smallest detectable change and minimal important change (MIC) for the small fiber neuropathy screening list (SFNSL) in sarcoidosis, Sarcoidosis Vasc Diffuse Lung Dis, 35, 333
- Lower, 2019, Presence of onconeural antibodies in sarcoidosis patients with parasarcoidosis syndrome, Sarcoidosis Vasc Diffuse Lung Dis, 36, 254
Cited by
Wijsenbeek, M., Suzuki, A., & Maher, T. M. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01052-2 · Cited by 539
Diagnosis and Treatment of Pulmonary Sarcoidosis: A Review
Belperio, J. A., Shaikh, F., Abtin, F. G., Fishbein, M. C., Weigt, S. S., Saggar, R., & Lynch, J. P. (2022) · JAMA · doi:10.1001/jama.2022.1570 · Cited by 191
Kidney manifestations of sarcoidosis.
Bonella, F., DM Vorselaars, A., & Wilde, B. (2024) · Journal of autoimmunity · doi:10.1016/j.jaut.2024.103207 · Cited by 32
Self-citation
Metadata
- Authors
- Baughman, R. P., Valeyre, D., Korsten, P., Mathioudakis, A. G., Wuyts, W. A., Wells, A., Rottoli, P., Nunes, H., Lower, E. E., Judson, M. A., Israel-Biet, D., Grutters, J. C., Drent, M., Culver, D. A., Bonella, F., Antoniou, K., Martone, F., Quadder, B., Spitzer, G., Nagavci, B., Tonia, T., Rigau, D., & Ouellette, D. R.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2021-06-17
- Volume
- 58
- Issue
- 6
- Pages
- 2004079
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W3166756865
- Cited by
- 629
- References
- 184
- FWCI
- 50.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.